Glow-and-Kill surgery: new light therapy targets hidden cancer cells
NCT ID NCT06307548
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a two-step approach during surgery for people with advanced or returning colorectal cancer. First, a drug makes cancer cells glow under blue light so surgeons can see and remove them. Then, red laser light activates the drug to kill any remaining cancer cells. The goal is to improve tumor control and reduce recurrence. About 21 adults will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Roswell Park Cancer Institute
RECRUITINGBuffalo, New York, 14263, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Acupuncture needles aim to zap cancer brain fog
- Experimental combo targets Hard-to-Treat GI cancers
- Can a common drug help cancer patients regain appetite?
- Blood test could decide who needs stronger or milder chemo for colorectal cancer
- Blood test could spot lingering cancer after colon surgery
- FITBIT FOR CANCER: STUDY TESTS IF STEP COUNTS PREDICT SURVIVAL